Aaron Mehus

Dr. Aaron Mehus

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2019 in The Journal of Nutritional Biochemistry
Verified
Journal Article
Closed access
PŽPetr Žáček
Petr Žáček
MBMichael Bukowski
Michael Bukowski
AMAaron Mehus
Aaron Mehus
LJLuAnn Johnson
LuAnn Johnson
HZHuawei Zeng
Huawei Zeng
MPMatthew Picklo
Matthew Picklo

1 April 2014 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
PDF file
AMAaron Mehus
Aaron Mehus
WMWallace W. Muhonen
Wallace W. Muhonen
SGScott H. Garrett
Scott H. Garrett
SSSeema Somji
Seema Somji
DSDonald A. Sens
Donald A. Sens
JSJohn B. Shabb
John B. Shabb
Human metallothioneins (MTs) are important regulators of metal homeostasis and protectors against oxidative damage. Their altered mRNA expression has been correlated with metal toxicity and a variety of cancers. Current immunodetection methods lack the specificity to distinguish all 12 human isoforms. Each, however, can be distinguished by the mass of its acetylated, cysteine-rich, hydrophilic N-terminal tryptic peptides. These properties were exploited to develop a bottom-up MALDI-TOF/TOF-MS-based method for their simultaneous quantitation. Key features included enrichment of N-terminal acetylated peptides by strong cation exchange chromatography, optimization of C18 reversed-phase chromatography, and control of methionine oxidation. Combinations of nine isoforms were identified in seven cell lines and two tissues. Relative quantitation was accomplished by comparing peak intensities of peptides generated from pooled cytosolic proteins alkylated with 14N- or 15N-iodoacetamide. Absolute quantitation was achieved using 15N-iodoacetamide-labeled synthetic peptides as internal standards. The method was applied to the cadmium induction of MTs in human kidney HK-2 epithelial cells expressing recombinant MT-3. Seven isoforms were detected with abundances spanning almost 2 orders of magnitude and inductions up to 12-fold. The protein-to-mRNA ratio for MT-1E was one-tenth that of other MTs, suggesting isoform-specific differences in protein expression efficiency. Differential expression of MT-1G1 and MT-1G2 suggested tissue- and cell-specific alternative splicing for the MT-1G isoform. Protein expression of MT isoforms was also evaluated in human breast epithelial cancer cell lines. Estrogen-receptor-positive cell lines expressed only MT-2 and MT-1X, whereas estrogen-receptor-negative cell lines additionally expressed MT-1E. The combined expression of MT isoforms was 38-fold greater in estrogen-receptor-negative cell lines than in estrogen-receptor-positive cells. These findings demonstrate that individual human MT isoforms can be accurately quantified in cells and tissues at the protein level, complementing and expanding mRNA measurement as a means for evaluating MTs as potential biomarkers for cancers or heavy metal toxicity.

1 January 2016
Verified
Book Chapter
Closed access
AMAaron Mehus
Aaron Mehus
RARuthellen H. Anderson
Ruthellen H. Anderson
Kyle RouxKyle Roux
Kyle Roux

19 November 2009 in Chemical Research in Toxicology
Verified
Journal Article
Closed access
SSSeema Somji
Seema Somji
XZXu Dong Zhou
Xu Dong Zhou
AMAaron Mehus
Aaron Mehus
MSMary Ann Sens
Mary Ann Sens
SGScott H. Garrett
Scott H. Garrett
DSDonald. A. Sens
Donald. A. Sens

5 April 2019 in Anticancer Research
Verified
Journal Article
Closed access
PDF file
LYLin Yan
Lin Yan
SSSneha Sundaram
Sneha Sundaram
AMAaron Mehus
Aaron Mehus
MPMatthew J. Picklo
Matthew J. Picklo
Background/Aim: Obesity is a risk factor for cancer. Disruption of the daily feeding and fasting rhythm can contribute to obesity. This study tested the hypothesis that time-restricted feeding (TRF) attenuates obesity-enhanced metastasis. Materials and Methods: In a spontaneous metastasis model of Lewis lung carcinoma (LLC), male C57BL/6 mice were fed the standard AIN93G diet or a high-fat diet (HFD) with or without dark-phase restricted feeding (12 h per day) for 10 weeks. Pulmonary metastases from a subcutaneous tumor were quantified. Results: The number and size of lung metastases were greater in the HFD group than in the AIN93G group, but did not differ between the TRF and AIN93G groups. TRF prevented HFD-induced increases in plasma concentrations of glucose, insulin, proinflammatory cytokines (leptin, monocyte chemotactic protein-1, plasminogen activator inhibitor-1), and angiogenic factors (angiopoietin-2, hepatic growth factor, vascular endothelial growth factor). Conclusion: TRF attenuates the HFD-enhanced spontaneous metastasis of LLC in mice.

1 July 2015 in Journal of Occupational and Environmental Medicine
Verified
Journal Article
Open access
AMAaron Mehus
Aaron Mehus
RRRustin J. Reed
Rustin J. Reed
VLVivien S. T. Lee
Vivien S. T. Lee
SLSally R. Littau
Sally R. Littau
CHChengcheng Hu
Chengcheng Hu
JBJefferey Burgess
Jefferey Burgess
To investigate the comparative acute health effects associated with exposures to diesel and 75% biodiesel/25% diesel (B75) blend fuel emissions. We analyzed multiple health endpoints in 48 healthy adults before and after exposures to diesel and B75 emissions in an underground mine setting-lung function, lung and systemic inflammation, novel biomarkers of exposure, and oxidative stress were assessed. B75 reduced respirable diesel particulate matter by 20%. Lung function declined significantly more after exposure to diesel emissions. Lung inflammatory cells along with sputum and plasma inflammatory mediators increased significantly to similar levels with both exposures. Urinary 8-hydroxydeoxyguanosine, a marker of oxidative stress, was not significantly changed after either exposure. Use of B75 lowered respirable diesel particulate matter exposure and some associated acute health effects, although lung and systemic inflammation were not reduced compared with diesel use.